Compare with Bristol-Myers Squibb Company 6.875% 01-AUG-2097
Key terms
Details
Sector
Health Technology
Industry
Pharmaceuticals: Major
Home page
ISIN
US110122AC22
CUSIP
110122AC2
FIGI
BBG00004NXF6
Identifiers
ISIN US110122AC22
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.
Sign up to see advanced bond data
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.